v3.26.1
Note 14 - Stockholders' Equity (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 15, 2025
Feb. 28, 2026
Aug. 31, 2025
Feb. 28, 2025
Nov. 30, 2024
Feb. 28, 2026
Feb. 28, 2025
May 31, 2024
Nov. 30, 2025
May 31, 2025
Shares Authorized, Total (in shares)   1,426,000,000       1,426,000,000        
Common Stock, Shares Authorized (in shares)   1,416,000,000       1,416,000,000       1,416,000,000
Preferred Stock, Shares Authorized (in shares)   10,000,000       10,000,000       10,000,000
Common Stock, Shares, Issued (in shares)   116,546,939       116,546,939       106,067,875
Treasury Stock, Common, Shares (in shares)   321,391       321,391       200,422
Preferred Stock, Shares Issued (in shares)   0       0       0
Proceeds from Issuance of Common Stock           $ 73,058 $ 139,738      
Stock Issued During Period, Shares, Warrants Exercised (in shares) 620,900         620,900        
Stock Issued During Period, Shares, Settlement of Financing Liability (in shares)           861,707        
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)           980,703        
Stock Cancelled During Period, Shares, Reverse Stock Splits (in shares)           20,652        
Share-Based Payment Arrangement, Expense   $ 13,725   $ 4,035   $ 31,060 $ 18,189      
Common Stock, Shares, Outstanding (in shares)   116,546,939       116,546,939       106,067,875
Time-based Restricted Stock Units [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)           4,554,321        
Performance-based Restricted Stock Units [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)               756,615    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number (in shares)   744,117       744,117     756,615  
Additional Paid-in Capital [Member]                    
Stock Issued During Period, Shares, Settlement of Financing Liability (in shares)           14,821        
TLRY 27 [Member]                    
Stock Issued During Period, Value, Repurchase of Convertible Securities     $ 4,800 26,443 $ 17,085          
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature           $ 1,158        
Shares Returned From Share Lending Agreement, Treasury Stock (in shares)   120,969,000       120,969        
TLRY 27 [Member] | Additional Paid-in Capital [Member]                    
Stock Issued During Period, Value, Repurchase of Convertible Securities     $ 4,799 $ 26,440 $ 17,084          
Conversion of TLRY 27 Notes to Shares [Member]                    
Stock Issued During Period, Shares, Repurchase of Convertible Securities (in shares)           1,259,182        
Stock Issued During Period, Value, Repurchase of Convertible Securities           $ 4,800        
Debt Instrument, Amount Repurchased           $ 5,000        
At-the-Market Program [Member]                    
Stock Issued During Period, Shares, New Issues (in shares)           6,777,224        
Proceeds from Issuance of Common Stock           $ 76,643        
Net Proceeds from Issuance of Common Stock           73,056        
Payments of Stock Issuance Costs           $ 3,587